You just read:

Merrimack to Present New Analyses of Phase 3 NAPOLI-1 Data at the ESMO 18th World Congress on Gastrointestinal Cancer

News provided by

Merrimack Pharmaceuticals, Inc.

Jun 21, 2016, 16:32 ET